79 related articles for article (PubMed ID: 10450045)
1. Failure of urinary and serum hepatocyte growth factor assay as an early marker of diabetic nephropathy.
Ebihara I; Nakamura T; Ushiyama C; Suzuki S; Koide H
Nephron; 1999; 82(4):365. PubMed ID: 10450045
[No Abstract] [Full Text] [Related]
2. Utility of serum and urinary transforming growth factor-beta levels as markers of diabetic nephropathy.
Mogyorósi A; Kapoor A; Isono M; Kapoor S; Sharma K; Ziyadeh FN
Nephron; 2000 Oct; 86(2):234-5. PubMed ID: 11015017
[No Abstract] [Full Text] [Related]
3. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S
Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 in type 2 diabetes: from cell first-line defense to early marker of diabetic nephropathy.
Pagnin E; Maiolino G; Calò LA
Minerva Med; 2016 Apr; 107(2):123-4. PubMed ID: 27064585
[No Abstract] [Full Text] [Related]
5. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
7. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B
Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966
[TBL] [Abstract][Full Text] [Related]
8. Applying proteomics to diagnosis of diabetic kidney disease.
Moresco RN; De Carvalho JAM
Expert Rev Proteomics; 2017 Oct; 14(10):841-843. PubMed ID: 28893107
[No Abstract] [Full Text] [Related]
9. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
10. [Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage].
Bao HL; Ye SH; Lou SX; Lu XW; Zhou XF
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1128-31. PubMed ID: 24956865
[TBL] [Abstract][Full Text] [Related]
11. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
[TBL] [Abstract][Full Text] [Related]
12. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
[TBL] [Abstract][Full Text] [Related]
14. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
15. Urinary meprin-alpha: a potential marker of diabetic nephropathy.
DeGuzman JB; Speiser PW; Trachtman H
J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1663-6. PubMed ID: 15645700
[No Abstract] [Full Text] [Related]
16. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
[TBL] [Abstract][Full Text] [Related]
18. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
19. [NGAL: a biomarker of acute and chronic renal dysfunction].
Lalanne A; Beaudeux JL; Bernard MA
Ann Biol Clin (Paris); 2011; 69(6):629-36. PubMed ID: 22123561
[TBL] [Abstract][Full Text] [Related]
20. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Togashi Y; Miyamoto Y
Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
